Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
Journal of the National Cancer Institute|October 1, 1977
In vivo growth advantage of the MOPC-315 mouse myeloma over its immunoselected variantsK Hannestad, M S Kao, R G Lynch, et al.American Journal of Obstetrics and Gynecology|September 1, 1993
Interferon alfa activates a lytic mechanism in ovarian and cervical carcinoma cellsC B Powell, T Horuchi, M S Kao, et al.The American Journal of Surgical Pathology|December 1, 1978
Proliferative serous tumors of the ovary. Histologic features and prognosisA L Katzenstein, M T Mazur, T E Morgan, et al.Gynecologic Oncology|June 1, 1987
Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final reportC A Perez, H M Camel, M S Kao, et al.Cancer Research|February 15, 1992
Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alphaD G Mutch, C B Powell, M S Kao, et al.Gynecologic Oncology|November 1, 1985
Complications in patients receiving both irradiation and radical hysterectomy for carcinoma of the uterine cervixA J Jacobs, C A Perez, H M Camel, et al.American Journal of Obstetrics and Gynecology|May 1, 1986
The role of lymphangiography in vulvar carcinomaS A Weiner, J K Lee, M S Kao, et al.American Journal of Obstetrics and Gynecology|December 1, 1990
Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignanciesD G Mutch, L S Massad, M S Kao, et al.Gynecologic Oncology|September 1, 1989
In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatinD G Mutch, C B Powell, M S Kao, et al.Clinical and Experimental Immunology|March 1, 1990
Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatinC B Powell, D G Mutch, M S Kao, et al.Pageof 6